Development and Manufacturing
Taking biosimilars from concept to IND
Our biosimilar capabilities are designed to help provide patients worldwide with access to the most advanced life-saving and life-improving therapies available. We leverage our large molecule capabilities to develop biosimilars that have no meaningful difference from their reference product in terms of safety and efficacy and are more affordable than the originator drug. We also have extensive expertise in cell line development, PQA modulation and process development to maximize reduce the overall cost of goods during development.